Posted On: 12/05/2012 8:45:02 AM
Post# of 28499
![Avatar](https://investorshangout.com/images/ProfileImages/96181853_77_cool-background-random-color.jpg)
SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - Invivoscribe Technologies, Inc. (San Diego, California) announced today that it has entered into an agreement with Takara Bio, Inc. (Otsu, Shiga, Japan) under which it has been granted a series of licenses to facilitate and conduct patent covered tests for the presence of internal tandem duplication (ITD) mutations in the FLT3 gene.
View More
View More
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)